Florida Cancer Affiliates
Print Text Size
  • Home
  • About Us
  • Careers
  • Contact Us
  • Menu
  • For
    Patients
  • Treatments
    & Services
  • Locations
    & Physicians
  • Cancers &
    Blood Diseases
  • Clinical Trials
    & Research
  • For Medical
    Professionals
  • Pharmacy
  • About Us
  • Careers
  • Contact Us

Medical News on Cancer

Metastatic Breast Cancer: Bevacizumab Slows Progression, But Has No Impact On Survival

Jul 12, 2012

The cancer drug bevacizumab (AvastinĀ®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers... Read More

Fewer Iron Supplements During Pregnancy Work Just As Well For Preventing Anaemia

Jul 12, 2012

Taking iron supplements one to three times a week instead of every day is just as effective at preventing anaemia in pregnant women, according to the findings of a new Cochrane systematic review. The authors of the review also showed that women experienced fewer side effects when taking iron supplements intermittently rather than daily... Read More

New Mechanism That Might Promote Cancer's Growth And Spread In The Body Revealed By Study

Jul 12, 2012

Tiny vesicles released by tumors cells are taken up by healthy immune cells, causing the immune cells to discharge chemicals that foster cancer-cell growth and spread, according to a study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) and at Children's Hospital in Los Angeles... Read More

Potential New Treatment For Metastatic Colon Cancer

Jul 12, 2012

How does a tumor cell set up a signaling pathway in order to metastasize? Scientists at Technische Universitat Munchen's (TUM) Klinikum rechts der Isar and Helmholtz Zentrum Munchen have made a significant discovery in this area by studying colon cancer. They have learned that the tumor cells release certain proteins known as chemokines... Read More

Targeting Cancer With Decreased Toxicity: First-Of-Its-Kind Approach To Designing Nanomedicines

Jul 12, 2012

Researchers at Brigham and Women's Hospital (BWH) are the first to report a new approach that integrates rational drug design with supramolecular nanochemistry in cancer treatment. Supramolecular chemistry is the development of complex chemical systems using molecular building blocks... Read More

Patient Concerns And Misinformation Impede Treatment Of Menopausal Women

Jul 12, 2012

The Endocrine Society commissioned Lake Research Partners to conduct a national survey of 424 internal medicine, family practice and OB/GYN physicians about their attitudes and experiences related to treating menopausal symptoms... Read More

Bevacizumab Slows Progression Of Metastatic Breast Cancer But Has No Impact On Survival

Jul 12, 2012

The cancer drug bevacizumab (AvastinĀ®) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers... Read More

For Anemia Prevention During Pregnancy, Iron Supplements Need Not Be Taken Every Day

Jul 12, 2012

Taking iron supplements one to three times a week instead of every day is just as effective at preventing anaemia in pregnant women, according to the findings of a new Cochrane systematic review. The authors of the review also showed that women experienced fewer side effects when taking iron supplements intermittently rather than daily... Read More

Discovery Of Melanoma-Promoting Gene

Jul 11, 2012

Black skin cancer, also known as melanoma, is particularly aggressive and becoming increasingly common in Switzerland. Despite intensive research, however, there is still no treatment. Researchers from the University of Zurich have now discovered a gene that plays a central role in black skin cancer... Read More

Exploiting "Molecular Glues" To Target Disease Relevant Proteolytic Enzymes

Jul 11, 2012

Scientists at the University Medical Center of Johannes Gutenberg University Mainz in Germany identified a novel strategy to target the oncologically relevant protein-cleaving enzyme Taspase1. Taspase1 levels are not only elevated in cancer cells of patients with head and neck tumors and other solid malignancies but the enzyme is also critical for the development of leukemias... Read More

Previous Page   Next Page

For Medical Professionals

  • Overview
  • Patient Forms
  • Industry News

The US Oncology Network

  • For
    Patients
  • Treatments
    & Services
  • Locations
    & Physicians
  • Cancers
    & Blood Diseases
  • For Medical
    Professionals
  • Pharmacy
Florida Cancer Affiliates ©2025 All rights reserved. | Privacy Practices | Verbal Communications Form
Website by 30 Degrees North